- $4.4 BnWorld market, 2023
- $91.8 BnProjected, 2033
- 35.5%Growth a year (CAGR)
- 888Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$1.8 Bn
33.5% a year · 42% of the world -
2
China
$354 Mn
37% a year · 8% of the world -
3
Canada
$352 Mn
35.5% a year · 8% of the world -
4
Japan
$274 Mn
36% a year · 6.2% of the world -
5
Germany
$161 Mn
33.7% a year · 3.7% of the world -
6
France
$121 Mn
34.5% a year · 2.8% of the world -
7
UK
$114 Mn
33.5% a year · 2.6% of the world -
8
Brazil
$110 Mn
36.5% a year · 2.5% of the world -
9
Italy
$106 Mn
35% a year · 2.4% of the world -
10
Ecuador
$88 Mn
36.1% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)Digital Biomarkers by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $4.4 Bn | $91.8 Bn | 35.5% | – | 888 | Report on Digital Biomarkers in Global |
| North America | $2.2 Bn | $42.6 Bn | 34.5% | 50% | 224 | Report on Digital Biomarkers in North America |
| APAC | $924 Mn | $21.2 Bn | 36.8% | 21% | 138 | Report on Digital Biomarkers in APAC |
| Europe | $836 Mn | $15.9 Bn | 34.2% | 19% | 256 | Report on Digital Biomarkers in Europe |
| Latin America | $198 Mn | $4.4 Bn | 36.5% | 4.5% | 38 | Report on Digital Biomarkers in Latin America |
| Middle East | $176 Mn | $4 Bn | 36.5% | 4% | 2 | Report on Digital Biomarkers in Middle East |
| Africa | $66 Mn | $1.5 Bn | 37% | 1.5% | 15 | Report on Digital Biomarkers in Africa |
| US |
$1.8 Bn | $33.2 Bn | 33.5% | 42% | 194 | Report on Digital Biomarkers in US |
| China |
$354 Mn | $8.2 Bn | 37% | 8% | 81 | Report on Digital Biomarkers in China |
| Canada |
$352 Mn | $7.3 Bn | 35.5% | 8% | 52 | Report on Digital Biomarkers in Canada |
| Japan |
$274 Mn | $5.9 Bn | 36% | 6.2% | 6 | Report on Digital Biomarkers in Japan |
| Germany |
$161 Mn | $2.9 Bn | 33.7% | 3.7% | 52 | Report on Digital Biomarkers in Germany |
| France |
$121 Mn | $2.3 Bn | 34.5% | 2.8% | 80 | Report on Digital Biomarkers in France |
| UK |
$114 Mn | $2.1 Bn | 33.5% | 2.6% | 61 | Report on Digital Biomarkers in UK |
| Brazil |
$110 Mn | $2.5 Bn | 36.5% | 2.5% | 27 | Report on Digital Biomarkers in Brazil |
| Italy |
$106 Mn | $2.1 Bn | 35% | 2.4% | 74 | Report on Digital Biomarkers in Italy |
| Ecuador |
$88 Mn | $1.9 Bn | 36.1% | 2% | 0 | Report on Digital Biomarkers in Ecuador |
 Spain |
$85 Mn | $1.6 Bn | 34.5% | 1.9% | 74 | Report on Digital Biomarkers in Spain |
 India |
$80 Mn | $2.1 Bn | 38.5% | 1.8% | 5 | Report on Digital Biomarkers in India |
 Saudi Arabia |
$75 Mn | $1.7 Bn | 37% | 1.7% | 1 | Report on Digital Biomarkers in Saudi Arabia |
 Mexico |
$66 Mn | $1.4 Bn | 35.8% | 1.5% | 12 | Report on Digital Biomarkers in Mexico |
 Australia |
$53 Mn | $1.2 Bn | 37% | 1.2% | 21 | Report on Digital Biomarkers in Australia |
 South Africa |
$29 Mn | $653 Mn | 36.7% | 0.7% | 0 | Report on Digital Biomarkers in South Africa |
 UAE |
$22 Mn | $494 Mn | 36.5% | 0.5% | 1 | Report on Digital Biomarkers in UAE |
 Egypt |
$12 Mn | $287 Mn | 37% | 0.3% | 14 | Report on Digital Biomarkers in Egypt |
 Philippines |
$10 Mn | $210 Mn | 36% | 0.2% | 0 | Report on Digital Biomarkers in Philippines |
 Hong Kong |
$7 Mn | $158 Mn | 36.5% | 0.2% | 9 | Report on Digital Biomarkers in Hong Kong |
 Malaysia |
$7 Mn | $150 Mn | 35.7% | 0.2% | 3 | Report on Digital Biomarkers in Malaysia |
 Singapore |
$5 Mn | $115 Mn | 36.1% | 0.1% | 16 | Report on Digital Biomarkers in Singapore |
 Thailand |
$5 Mn | $113 Mn | 35.8% | 0.1% | 5 | Report on Digital Biomarkers in Thailand |
 Kenya |
$3 Mn | $70 Mn | 36.6% | 0.1% | 1 | Report on Digital Biomarkers in Kenya |
 New Zealand |
– | – | – | – | 5 | Report on Digital Biomarkers in New Zealand |
 Russia |
– | – | – | – | 3 | Report on Digital Biomarkers in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 1,513 papers since 2021
- Quantitative Facial Phenotyping and Age-Associated Differences in Sickle Cell Disease Using Interpretable Machine Learning. medRxiv : the preprint server for health sciences, 2026
- A digital biomarker of white-matter routing from diffusion MRI as an early biomarker of Alzheimer's disease. medRxiv : the preprint server for health sciences, 2026
- Voice as a Candidate Digital Biomarker: Preliminary Comparison of Classical Acoustic Analysis and Self-Supervised Learning Models. Journal of voice : official journal of the Voice Foundation, 2026
- Digital phenotyping of migraine aura. Frontiers in neurology, 2026
- Linguistic features from constrained spontaneous speech as potential markers of preclinical Alzheimer's disease. The journal of prevention of Alzheimer's disease, 2026
Compare Digital Biomarkers side by side
Key companies in Digital Biomarkers
AliveCor Inc.
Altoida Inc.
Amgen Inc.
Fitbit, Inc.
Biogen Inc
Bayer AG
GlaxoSmithKline Plc
Eli Lilly and Company
Quick answers
How big is the Digital Biomarkers market?
The world Digital Biomarkers market was worth about $4.4 Bn in 2023 and is projected to reach $91.8 Bn by 2033, growing 35.5% a year (CAGR).
Which country has the largest Digital Biomarkers market?
The US is the largest of the 24 countries we cover, at $1.8 Bn in 2023. India grows fastest, at 38.5% a year.
How many clinical trials are running in Digital Biomarkers?
ClinicalTrials.gov lists 888 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Digital Biomarkers?
PubMed lists about 1,513 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.